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NK cells are large granular lymphocytes that do not rearrangeTCR or Ig genes
(1) . They kill susceptible tumor or virus-infected cells in vitro without any MHC
restriction (2, 3), regulate antibody synthesis (4, 5), and mediate rejection ofbone
marrow cells (BMC)' in irradiated mice (6, 7) . Whether these functions are per-
formed by all NK cells or by distinct subsets is unknown. Unlike tumor cell lysis,
NK-mediated rejection ofBMC is highly specific, involving recognition of the H-2
linked hemopoietic histocompatibility-1 (Hh-1) antigen (8) . Because of the fine
specificity of Hh-1 recognition, it is possible thatNK cell-mediated BMC rejection
occurs through distinct subsets of NK cells that have receptors for Hh antigens .
The genes for the major Hh antigens, Hh-1, map to the murine MHC (H-2) be-
tween the S andD regions (9), but they do not appear to be class I genes (10) . There
are five Hh-1 antigens that can be expressed and seven different combinations of
the five antigens have been identified in mice (11) . Mice reject bone marrow grafts
that express incompatible Hh antigens, if the recipient mice have the necessary
non-MHC-linked responder genes (12) . Hh-1 expression is recessively inherited (8)
presumably because Hh-1 expression is regulated by dominant trans-acting down regula-
tory genes (13) . Consequently, Fl hybrid mice express only those Hh antigens that
are expressed by both of their parents, so they are often able to recognize parental
Hh-1 antigens as foreign and reject parentalBMC grafts, a phenomenon known as
"hybrid resistance."
In this report, data are presented describing a new mAb, SW5E6, which binds
to -50% ofmurineNK cells . Administration ofSW5E6 antibodies in vivo elimi-
nated the ability of recipient mice to reject Hh-Il but not Hh-1bBMC . This indi-
cates that the recognition of different Hh-1 antigens may occur by distinct subsets
ofNK cells in vivo . The characterization of the 5E6 + subset ofNK cells and the
possible role of the 5E6 molecule in Hh-1d recognition is discussed .
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Materials and Methods
Animals.
￿
All animals were bred and maintained in the mouse colony at the University
of Texas Southwestern Medical Center, except for the strains 129/J and B10.BR which were
purchased from The Jackson Laboratory (Bar Harbor, ME).
Production ofmAbs.
￿
1.25 x 106 purified and rIL-2 (Cetus Corp., Emeryville, CA) propa-
gated NK1.1' cells (1) from C57BL/6 mice (H-2°) were injected into a 129/J mouse (H-2°)
intrasplenically (14). The animal was immunized intrasplenically 8 wk later with 1.5 x 106
purified and rIL-2 propagated NK1.1' cells from C57BL/6 mice. 3 d after the final injec-
tion, the spleen was removed, a cell suspension was made, and the cells were mixed with
murine myeloma SP2/0 cells at a ratio of 5:1 . The cells were pelleted at 800 g for 2 min,
and the supernatant was discarded. Polyethelene glycol (0.4 ml PEG 1000, British Drug House,
Poole, UK) was added, and the cellswere resuspended with a pipette for 50 s. The tube was
closed and rolled on the counter top for 40 s. 1 ml of hybridoma media (DME, 10% NCTC
109; Irvine Scientific, SantaAna, CA), 0.15 g/liter oxalacetic acid, 8.33 mg/liter bovine pan-
creatic insulin, 13.6 mg/liter hypoxanthine, 3 .9 mg/liter thymidine, 0.22 mg/liter glycine,
penicillin/streptomycin) containing 20% FCS was added to the cells. The cell suspension was
then added, dropwise, to a flaskcontaining 38 ml of media containing 20% FCS and incu-
bated overnight at 37°C in a 5% 002/95% air atmosphere. The following day, the cells were
pelleted at 800 g for 4 min, the supernatant discarded, and the cells were resuspended in
HAT (hybridoma media with 0.16 mg/liter aminopterin) containing media. The cells were
placed in 96-well round-bottomed plates. The wells were examined for growth after 10 d,
and the supernatants from the wells containing hybridomas were tested for their ability to
bind to purified C57BL/6 NK1.1' cells but not to C57BL/6 thymocytes by flow cytometry.
The hybridomas that produced antibodies that bound to NK cells but not to thymocyteswere
isolated and cloned twice by limiting dilution for further analysis.
Generation of IL-2-activated NK Cells.
￿
Nylon wool nonadherent spleen cells were cultured
in 500 U/ml rIL-2 . After 2 d, the nonadherent cells were removed, and the adherent cells
washed by rinsing the flask with 5 ml of RPMI 1640 media three times. The nonadherent
cells were pelleted and the supernatant was added back to the adherent cells in the flask.
These adherent cells were cultured for another 5-7 d. Fresh medium containing rIL-2 was
added on the fourth day, if necessary. The cells were harvested and analyzed for cell surface
phenotype or used for cell sorting. The cells obtained from this culture were routinely 80-100%
NK1.I' .
Cell Surface Analysis.
￿
For staining, rIL-2-activated NK cells or nylon wool nonadherent
spleen cells were washed three times in the staining buffer, 1% fraction 5 BSA (Sigma Chem-
ical Co., St. Louis, MO) in PBS. Approximately 5 x 105 cells were used per sample and
were stained in 100141. Primary incubation was with staining buffer alone (negative control)
or the appropriate dilution of specific antibody (positive) for 30 min at 4°C followed by two
washes in staining buffer. Primary antibodies included: PK136 (anti-NK1.1), SW3A4, SW5E6,
500A2 (antiT3; provided by Dr. J . Allison, University ofCalifornia at Berkeley), and H02.2
(anti-Ly-2). In the secondary incubation, all samples were stained with 50 ill of the appro-
priate species and isotype-specific secondary antibodies for 30 min at 4°C (all from Jackson
Laboratories, West Grove, PA). After two further washes in staining buffer, the samples were
resuspended in 0.4 ml of staining buffer and analyzed on a FACSTAR flow cytometer (Becton
Dickinson & Co., Mountain View, CA).
Cell Sorting and Propagation.
￿
Cells were stained as described above and sorted on a FAC-
STAR flow cytometer. The sorted cells were propagated in medium containing 500 U/ml
rIL-2 and 2-ME (5 x 10-s M) and were plated at 1-2 x 104 cells per well in 96-well, round-
bottomed microtiter plates, as previously described (1).
NK Cell Assay.
￿
Spleens were excised from animals, and a cell suspension was made. The
red blood cells were lysed by hypotonic shock. Aliquots of 5 x 106 cells were treated with
either SW3A4 ascites (1 :50) and baby rabbit complement (BRC), SW5E6 (1 :20) and BRC,
or BRC alone. The samples were incubated for 45 min at 37°C. After washing, the cells were
assayed for their ability to lyse "Cr labeled YAC-1 tumor cells as previously described (15) .SENTMAN ET AL.
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Treatment ofAnimals with Antibodies.
￿
Animals received a single injection of antibodies in-
traperitoneally 3 d before lethal irradiation or lung clearance assay, with the exception of
anti-asialo GM1 (Wako Chemical Co., Dallas, TX)which wasgivenintravenously 1 dbefore
lethal irradiation. Antibodies were prepared by ammonium sulfate (50%) precipitation of
tissue culturesupernatants. 1.5 mg ofSW5E6 or control antibody, 22B5 (antiarsonate; kindly
provided by Dr. Donald Capra, University of Texas Southwestern Medical Center, Dallas,
TX), preparations were given to each recipient in the treatedgroups, and 1 mg ofanti-NKI.1
was given to each animal in the anti-NKI.l-treated group.
Stem Cell Growth Assay.
￿
Allmice were kept in conventional facilities butwere givenacidified
drinking watercontaining neomycin to preventsepsis afterwhole-body irradiation. Theanimals
were exposed to 8.6 Gy of 1s1Cs gamma irradiation (Gamma Cell 40; Atomic Energy Ltd.,
Ottawa, Ontario). Within 6h, the mice were infused with BMC in alateral tail vein. Growth
of donor-derived cells was assessed 5 d after the transfer of marrow cells. 60 min after each
mouse was given 10' M fluoro-deoxyuridine (0.15 ml i.p.) to inhibit endogenous deoxy-
thymidylic acid synthesis, each mouse was injected with 0.5 p.Ci 5-iodo-1251-2'-deoxyuridine
(IUdR), athymidine analogue and specific DNA precursor. The spleens were removed 16 h
after IUdR injection, and the 1251 radioactivity was measured.The geometric mean (95%
confidence limits) splenic uptake (%)values of injected IUdR were calculated foreach group
(15). All values have been normalized to the syngeneic control uptake value (100%).
Lung Clearance Assay.
￿
YAC-1 tumor cells (30 x 106) were incubated in 2 ml complete
medium with 25,ug/ml 5-fluorodeoxyuridine for 15 min and then 30 p.Ci of 125IUdR was
added, and the cellswere incubatedfor an additional 75 min at 37'C in 5% C02. Cells were
washed three times in HBSS and adjusted to 2 x 106/ml. In a volume of 0.5 ml, 106 YAC-1
cells (3-5 x 105 cpm) were injected into a lateral tail vein of individual mice. At 3 h after
injection the mice were killed, their lungs were removed, and the 1251 radioactivity was mea-
sured. Results areexpressed as thegeometricmean ofthe percentage recovery ofthe injected
radioactivity.
Lactoperoxidase-catalyzed Radioiodination.
￿
Nylon wool nonadherent spleen cells cultured in
IL-2, as described above, were harvested and washed in PBS. The cells were labeled with
Na125I (Amersham Corp., Arlington Heights, IL) as described (16). Labeled cells were
washed in PBS, were lysed in 0.5% NP-40 (Accurate Chemical and Scientific Corp., Hicks-
ville, NY), and were centrifuged at 2,500 g to remove nuclei. 5% FCS was added to inhibit
proteolysis.
Immunoprecipitation andSDS-PAGE.
￿
Lysates from radioiodinated cells were incubated with
Staphylococcus aureus coated Pansorbin Cells (Calbiochem-Behring Corp., La Jolla, CA)
and rabbit antisera to mouseimmunoglobulins (RAMIgs) (DakoCorp., SantaBarbara, CA)
for 30 min at 4°C to remove nonspecific binding components. Aliquots of the precleared
cells were incubated with specific antibodies for 2 h at 4°C and Pansorbin cells, coated with
RAMIgs, were added for an additional 40 min. The cells were pelleted and washed three
timeswith Tris-buffered saline (pH 8) containing 0.5 % NP-40, 0.2% sodium deoxycholate,
and 0.1 % SDS. The bound proteins were eluted from the cells by boiling them in 217o SDS
buffered with Tris (pH 6.8). Eluates were reduced with 10% 2-ME and were analyzed by
SDS-PAGE according to the method of Laemmli(17). Slab gels were dried andwere exposed
to x-ray film overnight at -70°C.
Statistics.
￿
Control samples of 1:100 dilution of the preparation of IUdR were counted.
Thepurity ofthe IUdR was90 %.The formulaused to calculatepercent IUdR incorporation
was: [1251 spleen or lung (cpm)]/[standard (cpm) x purity (0.9)] . The computed values were
converted to loglo numbers to calculate values of mean, SD, and SEM for each group. The
geometric means (95% confidence limits) were calculated. Here the arithmetic mean IUdR
uptake (%) values ofthe syngeneic groups (for BMC transplant experiments) were consid-
ered 100% growth, and each individual value was calculated as percent growth, whichis [ex-
perimental/mean syngeneic] x 100. The data are represented on an arithmetic scale and
mean t SEM values areshown. There were five to sevenanimals per group, andparametric,
nonparametric, and Student's t test were performed to determine if the mean values were
significantly different (p < 0.05).194
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Results
SW5E6 Antibodies Bind to -40-50% of Murine NK Cells.
￿
To determine whether
rejectionofHhincompatible BMCwas mediated bysubsets ofNKcells, mAbsagainst
NK cells were produced by immunizing 129/J (H-26) mice with purified NKIV
cells from C57BL/6 (H-2e) mice. NK1.1 is a pan NK-specific antigen present on mu-
rine NK cells (18). Several clones were isolated that produced antibodies thatbound
exclusively to NK cells but not to other lymphocytes (data not shown). None ofthe
antibodies stainedthetumorcelllines EL4(thymoma), RAW 309.E1.1 (macrophage),
P815 (mastocytoma), CTLL-2 (CTL), YAC-1 (thymoma), or 70Z (pre-B cell) (data
not shown). The staining profiles for two ofthese mAbs.on C57BL/6 NKIV cells
are shown in Fig. 1. SW3A4 is anIgM antibody thatbinds to all NK cells(Sentman,
C. L.,J. Hackett, V. Kumar, and M. Bennett, manuscriptin preparation). SW5E6,
on the otherhand, is an IgG2a antibody that bindsto-50% ofpurified IL-2-propa-
gated NK1.1+ cells. In experiments not shown, SW5E6 was found to bind -50%
of fresh, sorted splenic NKIV cells as well. 5E6+ cells were purified by cell sorting,
and a summary ofthose experiments is shown in Table I. When sorted cells were
cultured in rIL-2 and analyzed for cell surface antigen expression, the 5E6+ cells
obtained all expressed 5E6 and NKLI but not T3 (CD3), and their phenotype re-
mained stable after in vitro propagation in IL-2. The 5E6 - cells obtained consisted
of 5E6- NK cells and T3' T cells. Although most of the 5E6- cells were T cells,
the 5E6 - NK cells proliferated much better in 500 U/ml IL-2 than the T cells and
accounted for almost 50% of the final population on day 7. Thus the 5E6' cells
form a distinct and stable subset of murine NK cells.
SW5E6 and Complement Treatment of Spleen Cells Results in a 50% Reduction in NK
Cell LyticActivity. The datain Fig. 2 demonstratethat treatmentofspleen cellswith
SW3A4 (which binds toall NKcells) and complement removed allNK lysisofYAC-
1 tumor cells. In contrast, SW5E6 and complement removed some but not all of
the NK activity in every mouse strain tested, C57BL/6 (Hh-I'), B10.A(3R) (Hh-Id),
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FIGURE 1.
￿
Fluorescence histograms of NKIV cells stained
with (A)SW3A4or (B)SW5E6 InAbs. The solid line in each
histogramrepresents fluorescence with FITC labeledsecondary
alone, and the dotted line represents the fluorescence with
SW3A4 or SW5E6 followed by the FITC secondary, respec-
tively.Y
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TABLE I
Analysis of Sorted 5E6' Spleen Cells
2b 50 75 100 125
25 50 75 100 125
25 50 75 100 125
EFFECTOR : TARGET CELL RATIO
C57BL/6 nylon wool nonadherent spleen cells were sorted into 5E6' and5E6-
fractions (Exp. 1) or 5E6' and NK1.1 ` fractions (Exp. 2). Sorted cells were
placed in microtiter wells at 1-2 x 104 cells per well . The cells were stained
with the various antibodies indicated after 6-7 days in 500 U/ml of HL-2 .
The numbers indicate the percent of sorted and cultured cells that stained posi-
tive with various antibodies.
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FIGURE 2.
￿
Lytic activity of 5E6- spleen cells
against YAC-1. (. . . .) Spleen cells treated with
SW5E6 and complement, (- - -) spleen cells
treated with SW3A4 and complement, and
(
￿
) spleen cells treated with complement
alone.
Exp. Antibodies
Sorted nylon wool
nonadherent spleen cells'
5E6' 5E6-
1 PK136 (anti-NK1 .1) 97 47
SW5E6 97 3 .8
SW3A4 96 47
500A2 (anti-CD3) 3.0 53
5E6' NK1.1'
2 PK136 (anti-NK1 .1) 100 100
SW5E6 99 60196
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and B10.BR (Hh-I1) . Based on these data, it is evident that both 5E6+ and 5E6-
NK cells are capable of lysing YAC-1 tumor cells . The decrease in NK activity was
N50%, as assessed in lytic units, a finding that is consistent with the observation
that approximately one-half ofNK cells are 5E6+ .
Administration ofSW5E6 Antibodies Inhibits Rejection of Hh-Id BALBIc BMC but not
Hh-1e C57BL/6BMC. We next determined the role of5E6 + NK cells in the rejec-
tion ofBMC grafts . The data in Fig. 3 demonstrate that animals given anti-NK1 .1
(PK136), which has been previously shown to remove all NK cell activity in vivo
FIGURE 3 .
￿
Effect ofSW5E6on
the rejection of bone marrow
cells . Percent' 21IUdR incorpo-
ration in mice challenged with
either (A) BALB/c (Hh-1 °) or
(B)C57BL/6 (Hh-1°) BMC. All
recipient mice received 5 x 10 6
BMC, except C57BL/6 and
B10.A(3R), which received 3 x
106BMC. Recipient mice were
syngeneic BALB/c (A) or
C57BL/6 (B), or Hh-1 incom-
patible recipients indicated in
the figures which were un-
treated, treated with anti-NK1 .l
or treated with SW5E6 3 d be-
fore lethal irradiation andbone
marrow cell infusion. Datahave
been normalized to the syn-
geneic control group values for
each BMC transplant . An as-
terisk indicates groups that are
significantly different than the
untreated control group.SENTMAN ET AL .
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(19), were no longer able to reject H-2d/Hh-Id BALB/c or H-2b/Hh-Ib C57BL/6
BMC. In contrast, treatment of irradiated C57BL/6, (C3H x B6)F l , B10.BR, and
(NZB x B6)Ft recipient mice with SW5E6 antibody prevented rejection of Hh-Id
BALB/cBMC (Fig . 3A) but had no detectable effect upon the ability of B10.A(3R),
(C3H x B6)Ft, B10.BR, and (NZB x B6)Fl hosts to reject Hh-l' C57BL/6BMC
(Fig . 3 B) . Since the last three sets of recipients are capable of rejecting both Hh-I"
and Hh-Ib BMC grafts, these data force the conclusion that 5E6+ NK cells are
necessary for rejection of Hh-ld but not Hh-lb BMC grafts .
SW5E6 Does Not Mediate its Effects by Interacting with Stem Cells.
￿
It was possible
that theSW5E6 antibodies were interacting with Hh-IdBALB/c stem cells, but not
the Hh-Ib C57BL/6 stem cells, and in some way protectingthem from hostNK cells.
To test this possibility, BALB/c BMC were treated with SW5E6 and complement
in vitro, then transplanted into syngeneic BALB/c hosts and the stem cell activity
was measured 5 d later. The results from this experiment are shown in Fig. 4 . Treat-
ment ofBMC with SW3A4 (pan-NK) or SW5E6 and complement had no effect
on the stem cell activity ofBALB/cBMC compared with those treated with comple-
ment alone. However, treatment with anti-H-2D" antibodies did reduce stem cell
activity. These results indicate that SW5E6 does not interact with stem cells to mediate
its effect in vivo .
SW5E6 Treatment Partially Inhibits theAbility ofMice to Lyse YAC-1 Tumor Cells In Viva
￿
It
was of interest to determine the effect ofSW5E6 treatment on in vivo NK activity.
The ability of an animal to clear tumor cells from their lungs is considered to be
ameasurement ofin vivo NK activity (20) . The data is shown in Fig. 5 . WhenSW5E6
was injected into C57BL/6 (Hh-l'), B10.BR (Hh-1't), or B10.A(3R) (Hh-ld) mice, 3 d
before assay, it resulted in a partial loss of their ability to clear YAC-1 tumor cells
from their lungs . The groups treated with control antibodies 22B5 (antiarsonate)
had between 0.8 and 1.4% retention of 1251 in their lungs . Groups treated with the
pan-NK antibody, anti-NK1.1, had the largest retention of 1251-labeled YAC-' cells
in their lungs, between 17 and 36% . The groups treated with SW5E6 had between
3.7 and 8.0% retention of radiolabeled YAC-1 cells . SW5E6 had the least effe .-t on
lung clearance in the B10.A(3R) (which express HhId) recipients and a greater effect
in the strains C57BL/6 and B10.BR which do not express Hh-ld. 5E6+ NK cells are
FIGURE 4 .
￿
Effect ofSW5E6 on BALB/c
(Hh-1~ stem cell activity. Percent splenic
1251UdR incorporation in lethally irradi-
ated BALB/c mice infused with 2.5 x 106
syngeneic BALB/c BMC. The BALB/c
BMC were treated in vitro, before infu-
sion, with either baby rabbit complement
alone (®), SW3A4andcomplement (/),
SW5E6 and complement (®), or anti-
H-2Ddand complement (0) . One group
received no BMC (®) . Data have been
normalized to the complement alone con-
trol group (125IUdR uptake was 0.57%) .
An asterisk indicates that groups are
significantly different than thegroup that
received no BMC .198
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FIGURE 5 .
￿
Effect ofSW5E6 on lung clearance
activity. Percent I'll retention in the lungs 3 h
after intravenous infusion of "5IUdR labeled
YAC-1 tumor cells . Recipient mice were treated
with either control (22115) ([J),anti-NK1 .1 (N),
or SW5E6 antibodies (®) 3 d before assay. An
asterisk indicates that groups are significantly
different than the control group treated with
22B5 .
present in similar numbers in strains of mice which do and do not express Hh-Id
(data not shown) . These data indicate that both 5E6+ and 5E6- NK cells are
capable of lysing YAC-1 tumor cells in vivo.
SW5E6 Treatment Diferentially Inhibits the Ability of Mice to Lyse YAC-1 Tumor Cells
In Vivo after Lethal Irradiation . Transplantation ofBMC is done in lethally irradi-
ated recipients . The effect ofSW5E6 treatment on in vivo NK activity in lethally
irradiated micemay be differentthan that in unirradiated mice . Therefore the effect
ofSW5E6 on the ability ofmice to clearYAC-1 cells from their lungs was measured
in animals 1 d after lethal irradiation . The results for mice whose BMCdo not ex-
press Hh-I'are shown in Fig. 6A and those for mice whose BMC do express Hh-Id
in Fig . 6B. In all strains there was a partial loss ofNK activity in vivo after lethal
FIGURE 6.
￿
Effect of SW5E6 on lung clearance activity 1 day after lethal irradiation . Percent
1271 retention in the lungs 3 hafter intravenous infusion of Iz 5IUdR-labeled YAC-1 tumor cells .
Recipient mice were treated with either control (22115) (EI), anti-NKI .l (/, except BALB/c
recipients, which were given anti-asialo GMl 2 d before assay), or SW5E6 antibodies (®) 4
d before assay. All mice received 800rad 1 d before assay . Recipient mice inA are all non-Hh-1°
strains, and recipientmice in Bexpress Hh-1`t. An asterisk indicates that groups are significantly
different than the control group treated with 22115 .SENTMAN ET AL.
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FIGURE 7 .
￿
Immunoprecipitation of the molecule
recognized by the SW5E6 antibodies from IL-
2-activated NK cells . Immunoprecipitation of
I25I-labeled NK cells using either 22135 control
antibody or SW5E6 . The immunoprecipitable
material was obtained from (A) C57BL/6 (Hh-lb)
NK cells or (B) NZB (Hh-1~ NK cells and run
by SDS-PAGE under reducingconditions . The data
in C represent immunoprecipitable material from
C57BL/6 NK cells run by SDS-PAGE under non-
reducing conditions .
irradiation . The injection of anti-NK1 .1 resulted in significant additional impair-
ment in the ability to clear radiolabeled YAC-1 cells . However, the effectsofSW5E6
antibodies differed in mice based upon the expression of Hh-ld. In BALB/c and
B10.A(3R) mice, which express Hh-Id, administration of SW5E6 did not impair in
vivoNK activity abovethat which resulted from irradiationalone . In contrast, SW5E6
antibodies had a significant additional effect on lung clearance ability, equivalent
to that produced by treatment with anti-NK1 .l antibodies, in irradiated C57BL/6
(Hh-1°), B10.BR (Hh-Ik), and B6D2F1 (Hh-1"ull) mice (which do not express Hh-Id) .
5E6+ NK cells arepresent both in mice that express Hh-I' and mice that do not ex-
press Hh-I' one day after lethal irradiation (data not shown) . Thus it appears that
5E6+ NK cells are not capable of lysing YAC-1 tumor cells after lethal irradiation
in mice whose BMC express Hh-Id .
The 5E6 Molecule Exists on the Cell Surface as a Homodimer Consisting of Two 54,000
Mol Wt Subunits. Thedata in Fig . 7 represent immunoprecipitation of the5E6 mol-
ecule from C57BL/6 (Hh-I') NK cells (Fig. 7, A and C) or NZB (Hh4d) NK cells
(7 B) and separated on SDS-PAGE under reducing (A and B) and nonreducing (C)
conditions . TheSW5E6 antibodies precipitate aprotein ofapparent molecular weight
of 54,000 under reducing conditions in all strains tested, including C3H, (C3H x
C57BL/6)Ft , and (NZB x C57BL/6)FI mice (data not shown) . Interestingly, under
nonreducing conditions, the SW5E6 antibodies immunoprecipitate a molecule of
108-110 x 10 3 mol wt, suggesting that the 5E6 molecule exists as a homodimer on
the cell surface .
Discussion
NK cells do not express B or T cell receptors, and they have been considered
"nonspecific" effector cells . Yet, NK cells do exhibit specificity in the recognition of
Hh antigens and it has been difficult to understand how they accomplish this . NK
cells have Fc receptors for Ig and could potentially rejectBMC grafts using "natural
antibodies" via antibody-dependent cellular cytotoxicity (21) . However, mice with
severe combinedimmune deficiency (SLID), which are devoid ofIgs, also specifically
reject incompatible BMC, usingNK cells (22) . Thus, recognition may be a prop-
erty of the NK cell itself. The data presented in this report, that reactivity against
Hh4d antigens resides in a distinct subpopulation ofNK cells, strongly support this200
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notion. Elimination of the 5E6+ subset of NK cells abrogated the ability ofinbred
mice to resist an Hh-Id incompatible BMC graft, but their ability to resist an Hh-l'
incompatible BMC graft was unaffected.
The observation that both 5E6+ and 5E6- NK cells were capable of lysing YAC-
1 tumor cells in vitro and in vivo, yet differ in their ability to reject Hh-Id and Hh-
16 BMC, suggests that NK cells may use different mechanisms to recognize Hh an-
tigens on BMC and "target structures" on tumor cells.
In addition to reactivity to allogeneic stem cells, NK cells are known to interact
with autologous stem cells bothin vitro and invivo (23). Thomsonetal. (24) reported
that NK cells are capable of eliminating syngeneic stem cells in vivo after certain
viral infections. Therefore it is particularly interesting that Hh-ldmice (BALB/c and
B10.A(3R)), like Hh-l' and Hh-l' mice, possess functional 5E6+ cells that can lyse
YAC-1 cells (Figs. 2 and 5). Since 5E6+ cells (Hh-Id reactive) exist in Hh-1d mice,
some mechanism apparently prevents potentially self-reactive 5E6+ cells from
eliminating their own stem cells. This notion is supported by the differential effect
of SW5E6 antibodies on in vivo NK activity in mice whose BMC do or do not ex-
press Hh-11. When injected into mice, SW5E6 antibodies had a minimal effect on
the clearance ofYAC-1 cells in Hh-ld-type mice, but the effect in animals with other
Hh-1 types was much more pronounced (Fig. 5). This difference wasmoredramatic
after lethal irradiation (Fig. 6, A and B). Thus it seems that in Hh-Id mice, the func-
tion of5E6+ NK cells is somehow downregulated, by mechanisms that remain to
be explored. It will be interesting to investigate the role of 5E6+ NK cells in the
regulation of hemopoiesis in Hh-J' mice.
What would be the advantage ofhaving distinct subsets ofNK cells forHh-1 an-
tigens? Distinct subsets ofNK cells with different specificities forHh-1 antigens would
allowthe reactivity toan individual Hh-1 antigen tobe easily altered without affecting
other necessary NK cell functions. There is no evidence yet that the 5E6 molecule
itself is involved in the recognition ofthe Hh-Id antigen. Although the 5E6+ subset
appears to contain all Hh-Idreactive NK cells, it cannot be concluded that all 5E6+
cells express receptors for Hh-l'. However, if in fact all 5E6+ NK cells do express
receptors for Hh-Id, it seems surprising that such a large percentage of NK cells
would be devoted to recognition ofHh-Id but not to any of the other four Hh-1 an-
tigens. It isconceivable thatreceptors for Hh-1 antigens onNKcells are not clonally
distributed, i.e., NK cells may express more than one anti-Hh-1 receptor. Allelic ex-
clusion of Ig or TCR genes is necessary for the expression and regulation ofB and
T cell receptors that must recognize a potentially infinite number of foreign an-
tigens, but NK cells involved in the rejection ofBMC grafts only need to recognize
five or lessHh-1 antigens. Therefore, the mechanisms for the expression and regula-
tion ofNK cell receptors need not be similar to those used by other lymphocytes.
The advantage ofhaving NK cells able to recognize more than one Hh-1 antigen
would be that a larger amount ofthe NK cell pool could be responsive to each Hh-1
specificity. Although we have so far only detected subsets of NK cells specific for
the Hh-Id antigen, it will be interesting to investigate whether or not other func-
tions attributed to NK cells can be placed into distinct subsets.
Summary
NK cells demonstrate many immunefunctions both invitro andin vivo, including
the lysisoftumoror virus-infected cellsand therejection ofbone marrow allografts.SENTMAN ET AL.
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However it remains unclear whether or not all NK cells can mediate these various
functions or if NK cells exist in functionally distinct subsets. We have developed
a new NK-specific mAb, SW5E6, which binds to -50% of murine NK cells. The
5E6 antigen identifies a distinct and stable subset of NK cells and is expressed on
about one-half of fresh or rIL-2-activated murine NK cells. Both 5E6+ and 5E6-
NK cells are capable of lysing YAC-1 tumor cells in vitro and in vivo. By treating
animals with SW5E6, we demonstrate that the 5E6 + subset is necessary for the re-
jection of H-2d/Hh-Id but not H-26/Hh-Ib bone marrow cells. Thus NK cells exist
as functionally separable subsets in vivo.
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